TORONTO, May 9, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTC-BB:MEDIF) (FSE:MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter financial results for the period ended March 31, 2025, before markets open on Wednesday, May 14, 2025.
Read more at newswire.caMediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
Newswire.ca -
Fri May 9, 6:00AM CDT
Columnist
Contributor Content
Press Release
Sponsored Content
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.